South Korea Certifies First Healthcare MyData Gatekeepers in Digital Health Push

SEOUL - South Korea has designated Kangbuk Samsung Hospital, Kakao Healthcare, and the Catholic Medical Center as the nation's first certified organizations authorized to receive patients' medical data through the MyData framework, marking a significant milestone in the country's digital health transformation.

The certification program, overseen by the Ministry of Health and Welfare, enables these organizations to aggregate and manage personal health information from multiple sources with patient consent, facilitating more integrated healthcare delivery and supporting artificial intelligence development in medical applications. The initiative represents South Korea's strategy to leverage its advanced digital infrastructure for improving healthcare outcomes while maintaining strict data privacy protections.

Under the MyData framework, patients can authorize certified gatekeepers to collect comprehensive health records from various hospitals, clinics, pharmacies, and health screening centers. This consolidated data can then be used to provide personalized health management services, facilitate second medical opinions, and support clinical research with appropriate safeguards.

Kakao Healthcare, the medical subsidiary of technology conglomerate Kakao Corporation, brings extensive experience in digital platform development to the healthcare sector. The company operates telemedicine services and health information applications that serve millions of South Korean users, positioning it to integrate MyData capabilities into existing consumer-facing products.

Kangbuk Samsung Hospital, one of South Korea's leading medical institutions, plans to utilize MyData capabilities to enhance continuity of care for patients receiving treatment across multiple facilities. Hospital administrators indicated that consolidated health records would reduce redundant testing, improve diagnostic accuracy, and enable more informed treatment planning.

The Catholic Medical Center, operating multiple hospitals across South Korea, emphasized that MyData certification would support its academic mission by facilitating de-identified research datasets that could advance medical knowledge while protecting individual privacy. Researchers at Catholic-affiliated institutions are particularly interested in using aggregated data for chronic disease management studies and treatment outcome analysis.

South Korea's government has been systematically building digital health infrastructure since 2020, when it began assisting hospitals in establishing data systems and implementing standardized electronic health record formats. The MyData initiative extends these earlier efforts by creating mechanisms for patient-controlled data sharing across institutional boundaries.

The Ministry of Health and Welfare announced plans to expand the MyData ecosystem gradually, with additional organizations expected to receive certification throughout 2026. Regulators emphasized that certification requirements include robust cybersecurity measures, transparent data governance policies, and clear consent management systems that give patients meaningful control over their information.

Simultaneously, South Korea is developing a National AI-Ready Health Data Infrastructure that will link clinical data from three major national university hospitals to the existing Health and Medical Big Data Platform. This integration, scheduled for completion in the second half of 2026, will provide researchers and AI developers with access to de-identified datasets for algorithm training and validation.

A particularly ambitious component of South Korea's digital health strategy involves creating a nationally integrated biobank database comprising genomic, clinical, and lifestyle data from 770,000 individuals. The $400 million project, first announced in late 2024, will begin providing public access in phases starting in 2026, with full accessibility targeted for 2028.

The Korea Disease Control and Prevention Agency is investing in graphics processing units to enhance cloud-based health data access services for public researchers. These computational resources will enable remote analysis of large datasets, supporting epidemiological studies, drug development research, and public health policy formation.

Meanwhile, the National Cancer Center Korea is constructing specialized infrastructure including public cancer data libraries covering eight major cancer types and a national cancer big data platform. These resources aim to accelerate precision medicine research by providing researchers with comprehensive, standardized cancer data.

Industry observers note that South Korea's coordinated approach to digital health infrastructure positions the country advantageously in the global race to apply artificial intelligence to medical diagnosis, treatment planning, and drug discovery. The combination of universal health insurance coverage, high digital literacy rates, and government support for technology innovation creates favorable conditions for healthcare AI development.

Technology companies beyond the three initial MyData gatekeepers are closely monitoring the certification process, with several major firms reportedly preparing applications. The MyData framework represents significant commercial opportunities as healthcare increasingly integrates digital services including remote monitoring, personalized wellness programs, and AI-assisted decision support.